Biofarmitalia

Biofarmitalia is an Italian pharmaceutical company specializing in the research, development, and manufacturing of innovative drug delivery systems, particularly transdermal patches and oral thin films. Founded in 1992 and based in Cologno Monzese, the company operates as a Contract Development and Manufacturing Organization (CDMO) serving the global pharmaceutical and nutraceutical markets. Their expertise includes the formulation of hydrogels, matrix patches, and oral dissolvable films for a variety of therapeutic applications such as pain management and hormone replacement. In 2022, Biofarmitalia was acquired by the French company AdhexPharma, integrating its specialized technical capabilities into a larger European transdermal delivery platform. The company provides end-to-end services from initial R&D and pilot-scale development to full-scale GMP industrial production.